Final Program

MONDAY • MAY 16 169
P901
P902
P903
P904
P905
Facilitator:
P906
P907
P908
P909
P910
P911
P912
P913
Lactate Is a Routinely Available Biomarker in COPD
Exacerbation of Prognostic and Therapeutic Significance/M.I.
MacDonald, K. Polkinghorne, I. Laska, M. Qiu, A. Barberi, C.
MacDonald, P. King, P.G. Bardin, Melbourne, Australia, p.A3486
Bacterial Colonization Is Associated with Abnormal Bronchial
Structure In Severe Chronic Obstructive Pulmonary Disease
(COPD) Patients/A. Rodrigo-Troyano, O. Sibila, G. Suarez-Cuartin,
S. Sjoqvist, N. Keune, L. Garcia-Bellmunt, A. Torrego, V. Plaza, R.
Faner, A. Agusti, P. Macchiarini, M.L. Lim, P. Jungebluth, Barcelona,
Spain, p.A3487
a1-Antitrypsin (A1AT) Serum Levels as Marker of Systemic
Inflammation in Non-A1AT-Deficient Patients with COPD/
B. Waschki, A.-M. Kirsten, O. Holz, T. Meyer, R. Lichtinghagen,
K.F. Rabe, H. Magnussen, T. Welte, H. Watz, S. Janciauskiene,
Grosshansdorf, Germany, p.A3488
SUV39H1 Reduction Is Implicated in Abnormal Inflammation of
COPD/T. Chen, S. Ho, H. Chuang, P. Feng, W. Liu, K. Chen, K.
Lee, New Taipei City, Taiwan, p.A3489
Blood Inflammatory Patterns in Chronic Obstructive
Pulmonary Disease: Relationship with Clinical Phenotypes/S.
Nayci, E.S. Ozgur, C. Ozge, Mersin, Turkey, p.A3490
C.P. Aaron, MD, New York, NY
The Relationship Between COPD Assessment Test and
C-Reactive Protein/H. Lee, H.K. Kang, K. Kim, I.A. Jeong, H.Y.
Park, Lee, D.G., Seoul, Korea, Republic of, p.A3491
Urinary Desmosines Are Associated with Emphysema Severity
in Patients with Chronic Obstructive Pulmonary Disease/C.
Kim, Y. Ko, Y.B. Park, Jeju-si, Korea, Republic of, p.A3492
Elevated Circulating PAI-1 Levels Are Relatd to Disease
Severity, Systematic Inflammation and Small Airway
Obstruction in Chronic Obstructive Pulmonary Disease/H.
Wang, T. Yang, T. Wang, F. Wen, Chengdu, China, p.A3493
Correlation Between Plasma Ghrelin Levels and
Breathlessness in Patients with Chronic Obstructive
Pulmonary Disease/N. Takeda, A. Sakai, H. Shibata, K. Oka, H.
Kitagawa, N. Yoshida, T. Katoh, M. Iwata, Kariya, Japan, p.A3494
Is the Seropositivity of Helicobacter Pylori Associated with the
COPD?; A Cross Sectional Association Study in an Asian Country
with High Prevalence of H. Pylori/H.Y. Lee, J.W. Kim, J.K. Lee, E.Y.
Heo, H.S. Chung, D.K. Kim, Seoul, Korea, Republic of, p.A3495
The Association Between Vitamin D and COPD Risk, Severity
and Exacerbation: A Systematic Review and Meta-Analysis
Update/M. Zhu, Y. Ji, Chengdu, China, p.A3496
Ultrafine Particles (UFPs) Content in Exhaled Breath Condensate
(EBC) of COPD Patients Is Decreased by Active Smoking/E.
Fireman Klein, E. Schiff, Y. Adir, A. Amital, A. Jacobi, S. Schneer, M.
Shteinberg, E. Fireman, A. Kessel, Haifa, Israel, p.A3497
Rating the Value of COPD Related Breath VOCs in Models
Created by Linear Discriminant Analysis/O. Holz, A. Gaida, C.
Nell, M. Allers, S. Schuchardt, S. Zimmermann, R. Koczulla, J.M.
Hohlfeld, Hannover, Germany, p.A3498
P914
Facilitator:
P915
P916
P917
P918
P919
P920
P921
P922
P923
B43
The Relationeship Between Pulmonary Function, HRCT Image,
Pulmonary Arterial Pressure and Urine Desmosine of COPD
Patients/M. Kato, Kishiwada, Osaka, Japan, p.A3499
S. Rosenberg, MD, Chicago, IL
Sputum-Plasma Ratio of Soluble Receptor for Advanced
Glycation End-Products in Patients with Chronic Obstructive
Pulmonary Disease/A.I. Baess, E.G. Hassanein, A.A. Elganady,
Y.A. Issa, E.M.A. Elakhtel, Alexandria, Egypt, p.A3500
Vitamin D Levels in Patients of COPD and Its Relation with
FEV1/FVC/V. Chopra, P. Kaur, H. Jain, V. Bamrah, K. N, Patiala,
India, p.A3501
Cystatin C Is Associated with Decline in Lung Function and
Incident Exacerbations of Chronic Obstructive Pulmonary
Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)
Lung Study/S.R. Viola, H. Mattix-Kramer, I. De Boer, B.
Kestenbaum, S. Mohan, J.E. Schwartz, M. Schlipak, R.G. Barr,
E.C. Oelsner, New York, NY, p.A3502
Association Between Serum Bilirubin and Risk of COPD
Exacerbations/K.E. Brown, D.D. Sin, H. Voelker, J.E. Connett,
K.M. Kunisaki, Minneapolis, MN, p.A3503
Adiponectin Is Associated with Lower Lung Function in Never
Smokers in a General Population-Based Sample/N.F.
Caspersen, A. Flyvbjerg, J. Frystyk, A. Randby, H. Hrubos-Strom,
S.K. Namtvedt, T. Omland, G. Einvik, Lorenskog, Norway, p.A3504
Metabolite Profiles of COPD and Pulmonary Function in the
Framingham Heart Study/D. Ngo, J. Latourelle, J. Dupuis, C.
Clish, T.J. Wang, G.T. O’Connor, R.E. Gerszten, Boston, MA,
p.A3505
Systemic Inflammation and Decline in Lung Function in Older
People: A Prospective Nationally-Representative from the
English Longitudinal Study of Ageing from 2004-2013/A.M.
Yohannes, G. Tampubolon, Manchester, United Kingdom, p.A3506
The Comparison of Proteases and Antiproteases in
Neutrophilic Asthma and Chronic Obstructive Pulmonary
Disease (COPD)/L. Jing, Z. Shi, C. Hua-ping, Y. Xu, D. Li-ping, W.
Chang-zheng, Chongqing, China, p.A3507
The Ideal Biomarker to Predict COPD Exacerbations/Z. Zafari,
D.D. Sin, S. Bryan, M. Sadatsafavi, Vancouver, Canada, p.A3508
THEMATIC POSTER SESSION
COPD: PHENOTYPES AND CLINICAL OUTCOMES
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area H, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
MONDAY MORNING
ATS 2016 • San Francisco